The APOE ɛ4 genotype has been shown to be the strongest single genetic factor associated with cerebrospinal fluid APOE protein levels, and APOE protein levels in cerebrospinal fluid may be a useful phenotypic biomarker for AD risk (Cruchaga et al., 2012[15]). The gene discussed is APOE; the disease is Alzheimer disease.